相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
Anna Kanerva et al.
CLINICAL CANCER RESEARCH (2013)
Oncolytic measles virus strains as novel anticancer agents
Pavlos Msaouel et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors
Don G. Morris et al.
INVESTIGATIONAL NEW DRUGS (2013)
Decoding cell death signals in liver inflammation
Catherine Brenner et al.
JOURNAL OF HEPATOLOGY (2013)
The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice
Diana M. Rommelfanger et al.
MOLECULAR THERAPY (2013)
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Jeong Heo et al.
NATURE MEDICINE (2013)
Trial watch Monoclonal antibodies in cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2013)
Improving the outcome of adoptive cell transfer by targeting tumor escape
Karen M. Kaluza et al.
ONCOIMMUNOLOGY (2013)
Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer
Weiyi Peng et al.
ONCOIMMUNOLOGY (2013)
Trial watch: DNA vaccines for cancer therapy
Laura Senovilla et al.
ONCOIMMUNOLOGY (2013)
Trial watch Cardiac glycosides and cancer therapy
Laurie Menger et al.
ONCOIMMUNOLOGY (2013)
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
Karsten Geletneky et al.
BMC CANCER (2012)
Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity
K. B. Stephenson et al.
CANCER GENE THERAPY (2012)
Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
Iulia Diaconu et al.
CANCER RESEARCH (2012)
Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients
Sari Pesonen et al.
CANCER RESEARCH (2012)
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2012)
Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies
Eleni M. Karapanagiotou et al.
CLINICAL CANCER RESEARCH (2012)
Recent Clinical Experience with Oncolytic Viruses
O. G. Donnelly et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
Balveen Kaur et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope Glycoproteins
Camilo Ayala-Breton et al.
HUMAN GENE THERAPY (2012)
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors
Sari Pesonen et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride
Kathryn A. Skelding et al.
INVESTIGATIONAL NEW DRUGS (2012)
A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
James M. Burke et al.
JOURNAL OF UROLOGY (2012)
Phase II Trial of Intravenous Administration of Reolysin® (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma
Evanthia Galanis et al.
MOLECULAR THERAPY (2012)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
The secret ally: immunostimulation by anticancer drugs
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame
Marijke van Rikxoort et al.
PLOS ONE (2012)
How imiquimod licenses plasmacytoid dendritic cells to kill tumors
Martin Holcmann et al.
ONCOIMMUNOLOGY (2012)
Trial Watch Adoptive cell transfer immunotherapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Viral antigen mediated NKp46 activation of NK cells results in tumor rejection via NK-DC crosstalk
Fay Chinnery et al.
ONCOIMMUNOLOGY (2012)
Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity
Ravi A. Madan et al.
ONCOIMMUNOLOGY (2012)
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer
Helene Pere et al.
ONCOIMMUNOLOGY (2012)
Chemoimmunotherapy as long-term maintenance therapy for cancer
Nejat K. Egilmez et al.
ONCOIMMUNOLOGY (2012)
Parvoviruses-tools to fine-tune anticancer immune responses
Svitlana P. Grekova et al.
ONCOIMMUNOLOGY (2012)
Virus infections in tumors pave the way for tumor-directed DC-vaccines
Norman Woller et al.
ONCOIMMUNOLOGY (2012)
Virotherapy, gene transfer and immunostimulatory monoclonal antibodies
Jose I. Quetglas et al.
ONCOIMMUNOLOGY (2012)
TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy
Laurent Amiset et al.
ONCOIMMUNOLOGY (2012)
Oncolytic adenoviruses A potent form of tumor immunovirotherapy
Vincenzo Cerullo et al.
ONCOIMMUNOLOGY (2012)
Trial watch Monoclonal antibodies in cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Trial Watch Immunostimulatory cytokines
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Trial watch Dendritic cell-based interventions for cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Trial Watch Experimental Toll-like receptor agonists for cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Trial watch Chemotherapy with immunogenic cell death inducers
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Trial watch Prognostic and predictive value of the immune infiltrate in cancer
Laura Senovilla et al.
ONCOIMMUNOLOGY (2012)
Trial watch Peptide vaccines in cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Trial watch FDA-approved Toll-like receptor agonists for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Targeting PD-1/PD-L1 interactions for cancer immunotherapy
Laurence Zitvogel et al.
ONCOIMMUNOLOGY (2012)
Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
Mark S. Ferguson et al.
ADVANCES IN VIROLOGY (2012)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer
A. Nakao et al.
CANCER GENE THERAPY (2011)
Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy
S. Leveille et al.
CANCER GENE THERAPY (2011)
The emerging role of viruses in the treatment of solid tumours
M. G. Bourke et al.
CANCER TREATMENT REVIEWS (2011)
Illicit survival of cancer cells during polyploidization and depolyploidization
I. Vitale et al.
CELL DEATH AND DIFFERENTIATION (2011)
Enhanced Safety Profiles of the Telomerase-Specific Replication-Competent Adenovirus by Incorporation of Normal Cell-Specific microRNA-Targeted Sequences
Kumiko Sugio et al.
CLINICAL CANCER RESEARCH (2011)
Oncolytic poliovirus against malignant glioma
Christian Goetz et al.
FUTURE VIROLOGY (2011)
Pseudotyping Vesicular Stomatitis Virus with Lymphocytic Choriomeningitis Virus Glycoproteins Enhances Infectivity for Glioma Cells and Minimizes Neurotropism
Alexander Muik et al.
JOURNAL OF VIROLOGY (2011)
Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy
Timothy Kottke et al.
MOLECULAR THERAPY (2011)
Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
Song-Nan Zhang et al.
MOLECULAR THERAPY (2011)
A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma
Tae-Ho Hwang et al.
MOLECULAR THERAPY (2011)
Mitotic catastrophe: a mechanism for avoiding genomic instability
Ilio Vitale et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
I. Martins et al.
ONCOGENE (2011)
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
Benjamin Diop-Frimpong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
Howard L. Kaufman et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication
Brent J. Passer et al.
CANCER RESEARCH (2010)
Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with Rapamycin
XueQing Lun et al.
CANCER RESEARCH (2010)
A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic Diseases
Kristopher J. Kimball et al.
CLINICAL CANCER RESEARCH (2010)
Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
Kevin J. Harrington et al.
CLINICAL CANCER RESEARCH (2010)
Novel oncolytic viruses: Riding high on the next wave?
Marianne M. Stanford et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver
Sunil K. Geevarghese et al.
HUMAN GENE THERAPY (2010)
Attenuation of Vesicular Stomatitis Virus Encephalitis through MicroRNA Targeting
Elizabeth J. Kelly et al.
JOURNAL OF VIROLOGY (2010)
Transcriptional and Translational Dual-regulated Oncolytic Herpes Simplex Virus Type 1 for Targeting Prostate Tumors
Cleo Y. F. Lee et al.
MOLECULAR THERAPY (2010)
A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
John Nemunaitis et al.
MOLECULAR THERAPY (2010)
Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
Sonia Guedan et al.
MOLECULAR THERAPY (2010)
Delivering nanomedicine to solid tumors
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells
Erica M. Gomes et al.
CLINICAL CANCER RESEARCH (2009)
Reovirus-based therapy for cancer
Kevin Kelly et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Genetically engineered Newcastle disease virus for malignant melanoma therapy
D. Zamarin et al.
GENE THERAPY (2009)
Chemical Modification with High Molecular Weight Polyethylene Glycol Reduces Transduction of Hepatocytes and Increases Efficacy of Intravenously Delivered Oncolytic Adenovirus
Konstantin Doronin et al.
HUMAN GENE THERAPY (2009)
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Neil N. Senzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay
Xiaoyi Yang et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
Myxoma Virus Expressing Interleukin-15 Fails To Cause Lethal Myxomatosis in European Rabbits
Jia Liu et al.
JOURNAL OF VIROLOGY (2009)
The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation
Qian Zhang et al.
MOLECULAR GENETICS AND GENOMICS (2009)
A Herpes Oncolytic Virus Can Be Delivered Via the Vasculature to Produce Biologic Changes in Human Colorectal Cancer
Yuman Fong et al.
MOLECULAR THERAPY (2009)
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre- and Post-tumor Resection for Recurrent GBM
James M. Markert et al.
MOLECULAR THERAPY (2009)
Conditional and reversible disruption of essential herpesvirus proteins
Mandy Glass et al.
NATURE METHODS (2009)
Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
B. Yaacov et al.
CANCER GENE THERAPY (2008)
A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer
Laura Vidal et al.
CLINICAL CANCER RESEARCH (2008)
Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models
Shanthi Ganesh et al.
CLINICAL CANCER RESEARCH (2008)
Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus
J. Foloppe et al.
GENE THERAPY (2008)
Potential for efficacy of the oncolytic herpes simplex virus 1716 in patients with oral squamous cell carcinoma
Alastair T. M. Mace et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2008)
Development of PEGylated adenovirus vector with targeting ligand
Yusuke Eto et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
Byeong-Ho Park et al.
LANCET ONCOLOGY (2008)
Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor
Joanne Morrison et al.
MOLECULAR THERAPY (2008)
A let-7 microRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication
Robert E. Edge et al.
MOLECULAR THERAPY (2008)
Chemical control of protein stability and function in living mice
Laura A. Banaszynski et al.
NATURE MEDICINE (2008)
Engineering microRNA responsiveness to decrease virus pathogenicity
Elizabeth J. Kelly et al.
NATURE MEDICINE (2008)
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
Roberto Cattaneo et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Viral control of mitochondrial apoptosis
Lorenzo Galluzzi et al.
PLOS PATHOGENS (2008)
Seneca valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers
P. Seshidhar Reddy et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients
J. Nemunaitis et al.
CANCER GENE THERAPY (2007)
Oncolytic viruses in cancer therapy
Markus J. V. Vaha-Koskela et al.
CANCER LETTERS (2007)
Stem cell collection and gene transfer in Fanconi anemia
Patrick F. Kelly et al.
MOLECULAR THERAPY (2007)
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor
Jennifer C. C. Hu et al.
CLINICAL CANCER RESEARCH (2006)
The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer
L. Zhao et al.
CANCER GENE THERAPY (2006)
The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro
T. Alain et al.
BRITISH JOURNAL OF CANCER (2006)
Intratumoral injection of herpes simplex virus HF10 in recurrent head and neck squamous cell carcinoma
Yasushi Fujimoto et al.
ACTA OTO-LARYNGOLOGICA (2006)
Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy
Y. Liu et al.
CANCER GENE THERAPY (2006)
Pilot study of oncolytic viral therapy using mutant herpes simplex virus (HF10) against recurrent metastatic breast cancer
Hideto Kimata et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Oncolytic capacity of attenuated replicative Semliki Forest virus in human melanoma xenografts in severe combined immunodeficient mice
Markus J. V. Vaha-Koskela et al.
CANCER RESEARCH (2006)
Oncolysis of pancreatic tumour cells by a γ34.5-deleted HSV-1 does not rely upon Ras-activation, but on the Pl 3-kinase pathway
F. Sarinella et al.
GENE THERAPY (2006)
Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides
Anna R. Makela et al.
JOURNAL OF VIROLOGY (2006)
Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect
K-J Choi et al.
GENE THERAPY (2006)
Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines
Sateesh Krishnamurthy et al.
JOURNAL OF VIROLOGY (2006)
A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization
SA Laurie et al.
CLINICAL CANCER RESEARCH (2006)
Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma
Gaofeng Jiang et al.
CANCER BIOLOGY & THERAPY (2006)
Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment
R Cairns et al.
MOLECULAR CANCER RESEARCH (2006)
CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor-armed oncolytic adenovirus for the treatment of bladder cancer
N Ramesh et al.
CLINICAL CANCER RESEARCH (2006)
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
AI Freeman et al.
MOLECULAR THERAPY (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
HF10, an attenuated herpes simplex virus (HSV) type 1 clone, lacks neuroinvasiveness and protects mice against lethal challenge with HSV types 1 and 2
I Mori et al.
MICROBES AND INFECTION (2005)
Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme:: biological and clinical results
F Colombo et al.
CANCER GENE THERAPY (2005)
Influenza immunisation in children with solid tumours
J Chisholm et al.
EUROPEAN JOURNAL OF CANCER (2005)
Effects of Onyx-015 among metastatic colorectal cancer patients that have failed prior treatment with 5-FU/leucovorin
TR Reid et al.
CANCER GENE THERAPY (2005)
Epidemiology and outcomes of serious influenza-related infections in the cancer population
CD Cooksley et al.
CANCER (2005)
Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas
E Galanis et al.
GENE THERAPY (2005)
Current status of gendicine in China: Recombinant human Ad-p53 agent for treatment of cancers
ZH Peng
HUMAN GENE THERAPY (2005)
Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector
JWP Smyth et al.
GENE THERAPY (2005)
Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus
A Kanerva et al.
GENE THERAPY (2005)
Xenograft models for liver metastasis: Relationship between tumor morphology and adenovirus vector transduction
ZY Li et al.
MOLECULAR THERAPY (2004)
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer
GJ Bauerschmitz et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12
RJ Wong et al.
CLINICAL CANCER RESEARCH (2004)
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival
S Harrow et al.
GENE THERAPY (2004)
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
EA Chiocca et al.
MOLECULAR THERAPY (2004)
Recombinant vesicular stomatitis virus vectors as oncolytic agents in the treatment of high-grade gliomas in an organotypic brain tissue slice-glioma coculture model
CD Duntsch et al.
JOURNAL OF NEUROSURGERY (2004)
The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors
KM Bernt et al.
MOLECULAR THERAPY (2003)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity
M Obuchi et al.
JOURNAL OF VIROLOGY (2003)
Acquired resistance to cytolysis of the E1B-attenuated adenovirus, dl1520, in ovarian tumour cell lines
YT Kim et al.
CANCER GENE THERAPY (2003)
Common community respiratory viruses in patients with cancer - More than just common colds
KL Hicks et al.
CANCER (2003)
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer
O Hamid et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy
DE Post et al.
ONCOGENE (2003)
Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent mice
H Takakuwa et al.
ARCHIVES OF VIROLOGY (2003)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Avian reoviruses cause apoptosis in cultured cells:: Viral uncoating, but not viral gene expression, is required for apoptosis induction
L Labrada et al.
JOURNAL OF VIROLOGY (2002)
Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis
RR White et al.
ANNALS OF SURGERY (2002)
Age-dependent effects of repeated immunization with a first generation adenovirus vector on the immune response and transgene expression in young and old rats
I Massari et al.
EXPERIMENTAL GERONTOLOGY (2002)
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
AL Pecora et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Phase I trial of intraperitoneal injection of the E1B-55-kd-Gene -: Deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer
PA Vasey et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study
V Papanastassiou et al.
GENE THERAPY (2002)
Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin
S Olijslagers et al.
CANCER GENE THERAPY (2001)
The role of adenovirus E4orf4 protein in viral replication and cell killing
PE Branton et al.
ONCOGENE (2001)
Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses
TS Griffith et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice
D Grote et al.
BLOOD (2001)
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
T Todo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
KD Fisher et al.
GENE THERAPY (2001)
Intralesional injection of herpes simplex virus 1716 in metastatic melanoma
RM MacKie et al.
LANCET (2001)
A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds
R Bilbao et al.
GENE THERAPY (2000)
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
FR Khuri et al.
NATURE MEDICINE (2000)
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
DF Stojdl et al.
NATURE MEDICINE (2000)
Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas
N Shinoura et al.
CANCER GENE THERAPY (2000)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant
K Ikeda et al.
JOURNAL OF VIROLOGY (2000)
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
JN Parker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
